BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 4311985)

  • 1. Studies on the mode of action of alpha-methyldopa.
    Henning M
    Acta Physiol Scand Suppl; 1969; 322():1-37. PubMed ID: 4311985
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of different dopa decarboxylase inhibitors on the hypotensive response to alpha-methyldopa in rats.
    Henning M
    Br J Pharmacol; 1968 Sep; 34(1):233P-234P. PubMed ID: 5676035
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction of DOPA decarboxylase inhibitors with the effect of alpha-methyldopa on blood pressure and tissue monoamines in rats.
    Henning M
    Acta Pharmacol Toxicol (Copenh); 1969; 27(2):135-48. PubMed ID: 5819569
    [No Abstract]   [Full Text] [Related]  

  • 4. Liberation of alpha-methyldopamine as a "false" sympathetic transmitter after pretreatment of cats with alpha-methyldopa and disulfiram.
    Thoenen H; Haefely W; Gey KF; Hürlmann A
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 258(2):181-96. PubMed ID: 4385111
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of the action of m-tyrosine on blood pressure in the conscious rat: evidence for a central hypotensive effect.
    Rubenson A
    J Pharm Pharmacol; 1971 Jun; 23(6):412-9. PubMed ID: 4397179
    [No Abstract]   [Full Text] [Related]  

  • 6. Contribution of the central nervous system to the action of several antihypertensive agents (methyldopa, hydralazine and guanethidine).
    Baum T; Shropshire AT; Varner LL
    J Pharmacol Exp Ther; 1972 Jul; 182(1):135-44. PubMed ID: 5041650
    [No Abstract]   [Full Text] [Related]  

  • 7. Reserpine rigidity and adrenergic neurones.
    Morrison AB; Webster RA
    Neuropharmacology; 1973 Aug; 12(8):725-33. PubMed ID: 4795744
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of alpha-methyl dopa on the reserpine-induced suppression of motor activity and the conditioned avoidance response.
    Uretsky NJ; Seiden LS
    J Pharmacol Exp Ther; 1969 Jul; 168(1):153-62. PubMed ID: 4307318
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of methyldopa on the neurogenic component of the arterial blood pressure.
    Gomez HJ; Gomez B; Bonilla LJ
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):373-82. PubMed ID: 4342314
    [No Abstract]   [Full Text] [Related]  

  • 10. Depression of sympathetic nervous function by DL-alpha-monofluoromethyldopa, an enzyme-activated, irreversible inhibitor of L-aromatic amino acid decarboxylase.
    Fozard JR; Spedding M; Palfreyman MG; Wagner J; Möhring J; Koch-Weser J
    J Cardiovasc Pharmacol; 1980; 2(3):229-45. PubMed ID: 6156322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurogenic component in the experimental hypertensive rat.
    Finch L
    Pharmacology; 1971; 5(4):245-54. PubMed ID: 5088648
    [No Abstract]   [Full Text] [Related]  

  • 12. Central hypotensive effect of L-3,4-dihydroxyphenylalanine in the rat.
    Henning M; Rubenson A
    J Pharm Pharmacol; 1970 Aug; 22(8):553-60. PubMed ID: 4394527
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of epsilon amino caproic acid on adrenergic nerve function and tissue monoamine levels.
    Andén NE; Henning M; Obianwu H
    Acta Pharmacol Toxicol (Copenh); 1968; 26(2):113-29. PubMed ID: 4299609
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of L-DOPA on conditioned avoidance responding after behavioural suppression by alpha-methyltyrosine or reserpine in mice.
    Ahlenius S
    Neuropharmacology; 1974 Aug; 13(8):729-39. PubMed ID: 4444759
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood pressure and noradrenaline levels after treatment with alpha-methyldopa, alpha-methyldopamine and alpha-methyl-m-tyrosine.
    Henning M
    J Pharm Pharmacol; 1967 Nov; 19(11):775-9. PubMed ID: 4383705
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence that the hypotensive action of methyldopa is mediated by central actions of methylnoradrenaline.
    Henning M; Rubenson A
    J Pharm Pharmacol; 1971 Jun; 23(6):407-11. PubMed ID: 4397178
    [No Abstract]   [Full Text] [Related]  

  • 17. Pseudo-transmitters.
    Carlsson A
    J Neurovisc Relat; 1969; 31():Suppl 9:249+. PubMed ID: 4319514
    [No Abstract]   [Full Text] [Related]  

  • 18. The induction and antagonism of central nervous system stimulant-induced stereotyped behavior in the cat.
    Wallach MB; Gershon S
    Eur J Pharmacol; 1972 Apr; 18(1):22-6. PubMed ID: 5031271
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of drugs on the temperature-lowering effect of harmaline.
    Bruinvels J; Sourkes TL
    Eur J Pharmacol; 1968 Aug; 4(1):31-9. PubMed ID: 5692910
    [No Abstract]   [Full Text] [Related]  

  • 20. [Central nervous sympathetic depressant effects of alpha-methyldopa].
    Tauberger G; Kuhn P
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 268(1):33-43. PubMed ID: 4250102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.